| Description |
SMi are proud to present the 8th Annual Conference on Pain Therapeutics, bringing together the leading figures of the field to discuss, debate and learn about the latest in drug development.
Despite a variety of groundbreaking drug candidates in early and late-stages of development, the lack of a novel analgesic continues to be a pressing issue in the world of Pain Therapeutics.
This event gives you the opportunity to hear presentations on hot targets for pain therapeutics, clinical approaches to neuropathic pain and regulatory aspects of drug development.
Groundbreaking developments and updates to be covered include:
• HOT NEW TARGETS for effective pain relief
• SUCCESSFUL AND NOVEL approaches to neuropathic and neurological pain
• NEW AND EVOLVING ANALGESICS in development.
• THE RELEVANCE of translational pharmacology to neurological pain
• THE IMPORTANCE of animal pain models
Covering essential updates from the past 12 months, this conference will be delivered by an excellent panel of speakers including:
• Dr Rolf Karlsten, Director, Medical Science, AstraZeneca
• Dr Lisa Broad, Senior, In Vitro, Pharmacology, Eli Lilly
• Dr Tony Ho, Senior Director, Clinical Neurosciences, Merck
• Dr Joachim Scholpp, Associate Head Therapeutic Area CNS, Boehringer-Ingelheim
• Dr Aldemar Degroot, Scientist, Exploratory Development Department, Astellas
|
|
